Glycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by a licensed professional only, not for resale, MD Custom Rx, 19035 W Capitol Dr Ste 105, Brookfield, WI 53045.
Published April 30, 2014 · Recall initiated: November 13, 2013
Summary
FDA records drug Class I recall D-1252-2014, published April 30, 2014 and initiated November 13, 2013. Recalling firm: Brookfield Prescription Center Inc; Status: Terminated; Reported quantity: 25 Vials; Lot: Lot #: 10292013@15, Beyond Use Date: 11/28/2013. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Brookfield Prescription Center Inc
- Distributor
- WI
- Lot
- Lot #: 10292013@15, Beyond Use Date: 11/28/2013
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVPRIV® (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human GeneticApril 30, 2014
- FDATikosyn® (dofetilide) 500 mcg (0.5mg) capsules, 60-count bottle, Rx only Pfizer Labs, Division of Pfizer Inc.April 30, 2014
- FDAXIYOUJI QINGZHI CAPSULE, 300mg, 20 count boxApril 30, 2014
- FDADay Time Cold & Flu, Multi-Symptom, Non-Drowsy, Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 4, 6,April 30, 2014
- FDAJaDera, 100% Natural Weight Loss Supplement, capsules, 30 count bottleApril 30, 2014
- FDAOxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs,April 30, 2014
Questions about this recall
Was Glycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by a licensed professional only, not for resale, MD Custom Rx, 19035 W Capitol Dr Ste 105, Brookfield, WI 53045. recalled?
Yes. FDA published recall D-1252-2014 on April 30, 2014. Reported hazard: Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone